Thermo Fisher Scientific and clinical trial laboratory company Q2 Solutions are partnering on a plan to reduce the turnaround time for laboratory tests necessary for patients in oncology clinical trials.
Through the partnership, Q2 Solutions will use its assays and tests with Thermo Fisher's Ion Torrent Genexus system, a fully integrated next-generation sequencing platform. The goal is to reduce the time to clinical laboratory results, which are often required before patients can undergo experimental treatment in oncology clinical trials.